Cargando…
Decreased efficacy of a COVID-19 vaccine due to mutations present in early SARS-CoV-2 variants of concern
With the SARS-CoV-2 virus still circulating and evolving, there remains an outstanding question if variant-specific vaccines represent the optimal path forward, or if other strategies might be more efficacious towards providing broad protection against emerging variants. Here, we examine the efficac...
Autores principales: | Weidenbacher, Payton A.-B., Friedland, Natalia, Sanyal, Mrinmoy, Morris, Mary Kate, Do, Jonathan, Hanson, Carl, Kim, Peter S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326996/ https://www.ncbi.nlm.nih.gov/pubmed/37425802 http://dx.doi.org/10.1101/2023.06.27.546764 |
Ejemplares similares
-
Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 Spike ferritin nanoparticle vaccine antigen produced from two different cell lines
por: Kumru, Ozan S., et al.
Publicado: (2023) -
Simplified Purification
of Glycoprotein-Modified Ferritin
Nanoparticles for Vaccine Development
por: Weidenbacher, Payton, et al.
Publicado: (2022) -
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
por: Weidenbacher, Payton A.-B., et al.
Publicado: (2022) -
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
por: Weidenbacher, Payton A.-B., et al.
Publicado: (2023) -
Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
por: Weidenbacher, Payton A.-B., et al.
Publicado: (2023)